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Introduction
In industrialized countries, osteoarthritis affects more than one 
third of the adult population. Despite their clinical importance, 
the molecular mechanisms of joint morphogenesis are still un-
clear. The appendicular skeleton arises from the condensation 
of chondroprogenitor cells that undergo chondrocyte template 
formation that is subsequently replaced by bone to form the 
adult skeletal elements separated by cartilaginous joints. The 
synovial joints of the long bone elements form through seg-
mentation of the continuous cartilaginous template with loss at 
the sites of the developing joints, loss of differentiated chon-
drocytes, and emergence of a nonchondrocytic joint-forming 
cell population that undergoes condensation, fl  attens, and de-
velops an interzone that then cavitates to form the joint space 
within the articular cartilage (for review see Archer et al., 
2003). There is limited information on the mechanisms that 
regulate the complex multistep process that leads to joint inter-
zone formation. In fact, very few genes have been reported to 
be necessary and/or suffi  cient to initiate the joint formation 
process (namely Noggin, growth and differentiation factor-5 
[Gdf-5], and Wnt9a [previously known as Wnt14]; Storm et al., 
1994; Brunet et al., 1998; Hartmann and Tabin, 2001). The fac-
tors that induce the expression of these joint morphogenic 
molecules are undefi  ned; furthermore, the mechanisms that 
determine the emergence of joint interzone cells within the 
chondrogenic condensates are unclear.
TGF-βs elicit their signal binding to TGF-β type II recep-
tor (TβRII) that leads to the phosphorylation of TβRI and 
TβRII–TβRI complex formation, which then activates the sig-
naling cascade through R-Smad–dependent (Smad-2,-3,-4) and 
Smad-independent pathways. In human and mouse embryonic 
cartilage, TGF-βs are expressed in the endochondral template 
with high expression in the perichondrium (Millan et al., 1991; 
Pelton et al., 1991a,b; Lawler et al., 1994; Serra and Chang, 
2003). TβRI and TβRII have been reported to be expressed in 
the perichondrium and proliferative and differentiated chondro-
cytes (Serra and Chang, 2003).
Genetic manipulation of the TGF-β system genes have re-
vealed their critical but still undefi  ned roles in skeletogenesis 
(Serra et al., 1997; Ito et al., 2003; Baffi   et al., 2004; for review 
see Dunker and Krieglstein, 2000). Targeted germline deletion 
of the Tgfb2 gene in mice results in perinatal lethality, and mice 
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espite its clinical signiﬁ  cance, joint morphogene-
sis is still an obscure process. In this study, we 
determine the role of transforming growth factor β 
(TGF-β) signaling in mice lacking the TGF-β type II 
  receptor gene (Tgfbr2) in their limbs (Tgfbr2
PRX-1KO). In 
Tgfbr2
PRX-1KO mice, the loss of TGF-β responsiveness resulted 
in the absence of interphalangeal joints. The Tgfbr2
Prx1KO 
joint phenotype is similar to that in patients with sym-
phalangism (SYM1-OMIM185800). By generating a 
Tgfbr2–green ﬂ  uorescent protein–β–GEO–bacterial arti-
ﬁ  cial  chromosome β-galactosidase reporter transgenic 
mouse and by in situ hybridization and immunoﬂ  uores-
cence, we determined that Tgfbr2 is highly and speciﬁ  cally 
expressed in developing joints. We demonstrated that in 
Tgfbr2
PRX-1KO mice, the failure of joint interzone develop-
ment resulted from an aberrant persistence of differenti-
ated chondrocytes and failure of Jagged-1 expression. 
We found that TGF-β receptor II signaling regulates 
Noggin, Wnt9a, and growth and differentiation factor-5 
joint morphogenic gene expressions. In Tgfbr2
PRX-1KO growth 
plates adjacent to interphalangeal joints, Indian hedgehog 
expression is increased, whereas Collagen 10 expression 
decreased. We propose a model for joint development 
in which TGF-β signaling represents a means of entry to 
initiate the process.
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present several skeletal defects, including cleft palate, skull ossi-
fi  cation defects, shortened long bones, bifurcation of the sternum, 
and spina bifi  da occulta (Sanford et al., 1997). 50% of the Tgfb1 
ablated mice die early in utero before embryonic day (E) 10.5 
because of a preimplantation defect; mice that are born do not 
display any dysmorphic phenotype but die early from diffuse 
infl  ammation (Shull et al., 1992; for review see Dunker and 
Krieglstein, 2000). Tgfb3-null mice have cleft palate and ab-
normal lungs (Kaartinen et al., 1995). Variability in the skeletal 
phenotype in Tgfb-targeted disrupted mice can be the result of 
differential and overlapping expression patterns of the isoforms 
throughout the skeletogenesis process and, therefore, compen-
satory effects of the other isoforms when one is ablated. Simi-
larly,  R-Smad gene targeting in mice has lead to variable 
phenotypes from early lethality (Smad-2 and Smad-4 ablation) 
to normal phenotype at birth but progressive osteoarthritis and 
colon adenocarcinomas in adulthood (Smad-3 ablation; Sirard 
et al., 1998; Weinstein et al., 1998; Zhu et al., 1998; Yang et al., 
2001). TβRII is the only TβR that is capable of binding all of the 
TGF-β isoforms and eliciting functional signaling; therefore, its 
ablation will allow studies of TGF-β signaling that avoid the 
functional redundancy of the ligands and signaling pathways. 
Unfortunately, mice that are germline null for Tgfbr2 exhibit 
early embryonic lethality that makes it impossible to evaluate 
the role of TGF-β signaling in skeletogenesis (Oshima et al., 
1996). We have previously reported that in transgenic mice, 
overexpression of a dominant-negative Tgfbr2 (DNIIR) results 
in adult osteoarthritis (Serra et al., 1997). However, the pheno-
type was only observed in a few lines, most likely because 
expression was inconsistent and lacked tissue-specifi  c targeting 
(Serra et al., 1997). Furthermore, the TGF-β cell targets and the 
temporal window of essential function during the endochondral 
process are not well defi  ned. Conditional inactivation of Tgfbr2 
in differentiated chondrocytes results in mice without any long 
bone defects, leading to the conclusion that TGF-β signaling is 
not needed in the limb endochondral process (Baffi   et al., 2004). 
However, implanted TGF-β induces extra digit formation 
(Ganan et al., 1996). To circumvent the embryonic lethality of 
Tgfbr2 systemic ablation and to determine the role of TGF-β 
signaling in early limb bud development, we generated mice in 
which the TβRII signaling is conditionally inactivated in limb 
buds and in a subset of other mesenchyme tissues starting at 
E9.5 (Tgfbr2
PRX-1KO).
We show that in Tgfbr2PRX-1KO mice, TGF-β signaling 
ablation results in the following: (1) lack of interphalangeal 
joint development; (2) failure of joint interzone formation with 
a lack of Jagged-1 expression and aberrant survival of differen-
tiated chondrocytes that leads to the absence of segmentation 
within the chondrogenic condensates; (3) failure of joint mor-
phogenic marker expression, including Noggin, and increased 
bone morphogenic protein (BMP) activity in limb bud cultures; 
(4) a selective defect on the endochondral growth plate process 
adjacent to the interphalangeal joints at early and late chondro-
genesis with an increase of prehypertrophic chondrocyte mark-
ers and a decrease of terminally differentiated chondrocyte 
marker expression; and (5) midline defects and zeugopod and 
stylopod chondrodysplasia. Furthermore, using a TβRII reporting 
mouse and in situ and immunohistochemistry analyses, we have 
demonstrated that TβRII is highly and specifi  cally expressed in 
developing joints.
Results
TGF-𝗃 signaling is needed for joint 
development and to regulate midline 
and limb skeletogenesis
To conditionally inactivate the TGF-β signaling in limb 
buds, we crossed Tgfbr2
fl  ox/fl  ox homozygous females with Prx1-
 Cre(Cre
+);Tgfbr2
fl  ox double heterozygous males (Cre
+Tgfbr2
fl  ox/−) 
to generate Tgfbr2
Prx1KO mice (homozygous knockouts). New-
born Tgfbr2
Prx1KO mice showed abnormal forelimbs and hindlimbs 
(Fig. 1 A), which were confi  rmed by microcomputed tomography 
(micro-CT) imaging and Alizarin red/Alcian blue staining 
(Fig. 1, B and C). Tgfbr2
Prx1KO autopods lacked interphalangeal 
joint development, and, between the ossifi  cation centers of the 
phalanges, at the site where the joints should have been formed, 
there was a continuous pattern of cells with some bending, 
Figure 1.  TGF-𝗃 signaling regulates limb development and is essential for 
interphalangeal joint formation. (A–C) External morphology (A), micro-CT 
analysis (B), and Alizarin red/Alcian blue staining of newborn Tgfbr2
Prx1KO 
mutant (C, bottom) and Tgfbr2
ﬂ  ox/ﬂ  ox control (C, top) demonstrating that 
the mutant is smaller and has severe stylopod, zeugopod, and autopod 
defects. (D and E) Morphometric analysis of sectioned autopod forelimbs of 
newborn Tgfbr2
Prx1KO mutant (D) and Tgfbr2
ﬂ  ox/ﬂ  ox control (E) by hematoxy-
lin and eosin, indicating that the mutant lacked the proximal (Prox) and 
medial (Med) interphalangeal joints; sporadically, a distal interphalangeal 
joint (Dis) is observed (as in the third digit).TGF-β SIGNALING IN JOINT DEVELOPMENT • SPAGNOLI ET AL. 1107
and a distal interphalangeal joint was seen sporadically (Fig. 1, D 
and E). Forelimb and hindlimb interphalangeal joints were equally 
affected, and studies were performed either on forelimbs or 
hindlimbs, but mostly on both. The Tgfbr2
Prx1KO forelimb and 
hindlimb autopods displayed smaller ossifi  cation centers of 
the metacarpals, carpals, metatarsals, tarsals, and phalanges 
as compared with controls; phalanges were bent (clinodactyly; 
Fig. 2, A and B). Tgfbr2
Prx1KO zeugopods and stylopods were 
short with signs of chondrodysplasia (Fig. 2, A and B). The 
humerus lacked the deltoid tuberosity and, similar to the femur, 
had dysplastic widened, fl  aring, and poorly mineralized meta-
physes (Fig. 2, C and D).
The morphometric parameters of newborn Tgfbr2
Prx1KO 
mutants are summarized in Table I. Compared with control Cre
− 
siblings, mutants are shorter, and their length is more affected 
than their weight, as demonstrated by the higher ponderal index. 
This fi  nding indicates that in Tgfbr2
Prx1KO mutants, the skeletal 
growth is impaired by a primary defect on skeletogenesis and is 
not the result of a global intrauterine nutritional defect.
Tgfbr2
Prx1KO mice had several midline defects: they lacked 
sternum formation, had hypoplastic incisors, and lacked the 
parietal and interparietal bones, whereas the frontal and squamosal 
bones were reduced in size (Fig. 3, A–J). They were capable 
of suckling, but they experienced massive and progressively 
visible intracranial bleeding (although still alive) that, at the 
necropsy exam, occupied most of the brain and likely was the 
primary cause of death. Although it is possible that a respiratory 
insuffi  ciency caused by the lack of the sternum may be a con-
comitant cause of death, it is unlikely to be the primary cause 
considering the severity of the intracranial bleeding. Lack of 
parietal and interparietal bone development was confi  rmed by 
micro-CT analyses of living newborn Tgfbr2
Prx1KO mice, indi-
cating that loss was not caused by accidental removal of the 
vault during the Alizarin red/Alcian blue staining procedure 
(Fig. 3, I and J). The pelvic bones of Tgfbr2
Prx1KO mice were 
smaller and poorly mineralized with signs of chondrodyplasia 
(Fig. 3, E and F).
Because we observed skeletal defects in segments unex-
pected for the reported Prx-1–mediated Cre recombination, 
we decided to evaluate the Prx1-Cre expression pattern in 
Tgfbr2
Prx1KO mice by crossing females doubly homozygous for 
Tgfbr2
fl  ox/fl  ox and R26R loci (Tgfbr2
fl  ox/fl  ox-R26R) with males het-
erozygous for Prx1-Cre to generate Tgfbr2
Prx1KO-R26R mice. In 
the R26R mice, the ROSA26 locus is targeted by gene trapping 
Figure 2.  TGF-𝗃 signaling regulates the morphological features of limb 
stylopods, zeugopods, and autopods. (A–D) Alizarin red/Alcian blue limb 
skeletons were prepared from newborn Tgfbr2
Prx1KO mutants and Tgfbr2
ﬂ  ox/ﬂ  ox 
control mice. Mutants (left) showed smaller forelimbs (A) and hindlimbs (B) 
with bended zeugopods and autopods. Tgfbr2
Prx1KO humerus and femur stylo-
pods (C and D) were shorter, had a middle concavity, and showed dysplastic 
poorly mineralized metaphyses. Humerus (C) lacked the deltoid tuberosity.
Table I. Newborn morphometric parameters in Tgfbr2  
prx1KO and control Cre
− siblings (Tgfbr2
ﬂ  ox/ﬂ  ox;Tgfbr2
ﬂ  ox/−)
Genotype n Mean ± SD P-value
Body length (cm) Tgfbr2
prx1KO 
Tgfbr2
ﬂ  ox/ﬂ  ox;Tgfbr2
ﬂ  ox/−
9 
17
2.52 ± 0.17 
3.00 ± 0.28
0.0039
Body weight (g) Tgfbr2
prx1KO 
Tgfbr2
ﬂ  ox/ﬂ  ox;Tgfbr2
ﬂ  ox/−
9 
17
1.15 ± 0.08 
1.52 ± 0.37
0.0362
Ponderal index (g/cm
3) Tgfbr2
prx1KO 
Tgfbr2
ﬂ  ox/ﬂ  ox;Tgfbr2
ﬂ  ox/−
9 
17
7.37 ± 1.84 
5.70 ± 1.14
0.0086
Humerus length (cm) Tgfbr2
prx1KO 
Tgfbr2
ﬂ  ox/ﬂ  ox;Tgfbr2
ﬂ  ox/−
4 
8
0.28 ± 0.03 
0.51 ± 0.02
0.004
Radius length (cm) Tgfbr2
prx1KO 
Tgfbr2
ﬂ  ox/ﬂ  ox;Tgfbr2
ﬂ  ox/−
4 
8
0.15 ± 0.02 
0.39 ± 0.01
<0.0001
Ulna length (cm) Tgfbr2
prx1KO 
Tgfbr2
ﬂ  ox/ﬂ  ox;Tgfbr2
ﬂ  ox/−
4 
8
0.22 ± 0.008 
0.49 ± 0.007
0.004
Femur length (cm) Tgfbr2
prx1KO 
Tgfbr2
ﬂ  ox/ﬂ  ox;Tgfbr2
ﬂ  ox/−
4 
8
0.33 ± 0.01 
0.45 ± 0.03
<0.0001
Tibia length (cm) Tgfbr2
prx1KO 
Tgfbr2
ﬂ  ox/ﬂ  ox;Tgfbr2
ﬂ  ox/−
4 
8
0.25 ± 0.005 
0.45 ± 0.02
0.004
Body lengths (from the tip of the nose to the anus) were measured on anesthetized animals stretched on top of a ruler. Ponderal indexes were calculated using 
the formula of Roher as weight (grams)/(length [centimeters])
3 × 100 (Rohrer, 1921). Stylopod and zeupod lengths were measured in Alizarin red/Alcian blue–
stained elements.JCB • VOLUME 177 • NUMBER 6 • 2007  1108
so that Cre recombination results in LacZ expression (Soriano, 
1999). We found that in Tgfbr2
Prx1KO-R26R whole mount em-
bryos (E10.5), X-galactosidase staining was evident in the de-
veloping forelimbs and hindlimbs as well as in the skull and in 
the anterior midline region of the trunk (Fig. 4 A). In sections of 
E15.5  Tgfbr2
Prx1KO-R26R embryos, X-galactosidase staining 
was visualized in the skull, limbs, and in the oral, midline, and 
pelvic regions, which are areas where the Tgfbr2
Prx1KO newborn 
mutants showed substantial skeletal abnormalities (Fig. 4 B).
T𝗃RII is highly and speciﬁ  cally expressed 
in developing joints
Because the Tgfbr2
Prx1KO autopods lacked the interphalangeal 
joints, we decided to investigate the TβRII expression in devel-
oping joints. To this purpose, we modifi  ed bacterial artifi  cial 
chromosomes (BACs) to generate a Tgfbr2-GFP-β–GEO-BAC 
mouse reporter transgene containing both GFP and IRES-β-
GEO (LacZ/Neo) reporter genes. We found that in E12.5 (Fig. 
5 A, arrows) and 16.5 (Fig. 5 B) whole mount and E16.5 phalan-
geal sections (Fig. 5 C) of Tgfbr2-GFP-β–GEO-BAC embryos, 
Tgfbr2 is highly expressed in the interphalangeal joints. We 
have also noted that Tgfbr2 is highly expressed in the shoulder 
and elbow joints (Fig. 5 B) as well as in the knee and hip joints 
(not depicted). We have established fi  ve independent transgenic 
Tgfbr2-GFP-β–GEO-BAC lines that demonstrate Tgfbr2 joint 
expression. Tgfbr2 expression was similar in hindlimb and fore-
limb interphalangeal joints (unpublished data).
The Tgfbr2 joint expression pattern in Tgfbr2-GFP-β–
GEO-BAC mice was directly comparable with endogenous 
  expression. In fact, in situ hybridization studies revealed that in 
E16.5 Tgfbr2
fl  ox/fl  ox embryos, Tgfbr2 is highly expressed in the 
cells demarking the interphalangeal joint interzone and in the 
phalangeal prehypertrophic chondrocytes (Fig. 5 D, middle). 
Immunofl  uorescence studies confi  rmed TβRII joint expression 
(Fig. 5 D, top). Furthermore, there was an intense staining of phos-
phorylated Smad-2 in the interzone cell nuclei (Fig. 5 D, bottom). 
In Tgfbr2
Prx1KO mutants, the lack of joints was accompanied by 
Figure 3.  Lack of TGF-𝗃 signaling determines axial, pelvic bones, and 
calvaria defects. (A–H) Alizarin red/Alcian blue ribcage (A and B), man-
dibular (C and D), pelvis (E and F), and calvaria (G and H) skeletons were 
prepared from newborn Tgfbr2
Prx1KO mutants and Tgfbr2
ﬂ  ox/ﬂ  ox control 
mice. In Tgfbr2
Prx1KO mice, the ribcage is open, lacking sternum develop-
ment (A); the incisors were hypoplastic (C), and the ischial (Is), pelvic (Pe), 
and iliac (Ic) bones (marked by arrows) were smaller and chondrodysplas-
tic (D). Tgfbr2
Prx1KO mice lacked the parietal (Pa) and interparietal (Ip) 
bones, whereas the supraoccipital (Su), exoccipital (Ex), frontal (Fr) and 
squamosal (Sq) bones were present but hypoplastic (G). (I and J) The lack 
of the parietal and interparietal bones was conﬁ  rmed by micro-CT analyses 
of living newborn Tgfbr2
Prx1KO mice, indicating that it was not caused by 
the accidental removal of the vault during the Alizarin red/Alcian blue 
staining procedure (I).
Figure 4.  Expression pattern of Prx-1–mediated Cre recombination in 
whole mount and sectioned Tgfbr2
Prx1KO-R26R embryos. (A and B) X-galac-
tosidase staining of a whole mount E10.5 Tgfbr2
Prx1KO-R26R embryo (A) 
and section of X-galactosidase–stained E15.5 Tgfbr2
Prx1KO-R26R embryo 
(B). Histological sections were lightly counterstained with Nuclear Fast red. 
In the E10.5 mutant embryo, the X-galactosidase blue staining, indicating 
a Cre-catalyzed recombination event, is visible through the forelimb (FL) 
and hindlimb (HL) buds, skull (SK), and anterior midline region (ML). In the 
E15.5 mutant embryo, Cre activity is additionally present in the pelvis (PE) 
and snout (SN) region (regions are marked by arrows). The expression 
pattern of PRX-1–mediated Cre recombination closely matches the regions 
where the Tgfbr2
Prx1KO mutant presents substantial skeletal abnormalities.TGF-β SIGNALING IN JOINT DEVELOPMENT • SPAGNOLI ET AL. 1109
the lack of Tgfbr2 mRNA and protein expression as well as 
a decrease of cell nuclei positive for phosphorylated Smad-2, 
indicating the effective Prx-1–mediated Cre recombination of 
Tgfbr2 (Fig. 5 D). Regarding the Tgfbr2 expression in the 
growth plate adjacent to the joints, we found that it was ex-
pressed at a much lower level than joints by cells that morpho-
logically resemble prehypertrophic chondrocytes (Fig. 5 D). 
PCR amplifi  cation of genomic DNA extracted by laser capture 
microdissection (LCM) from paraffi  n sections of E16.5 joint 
cells and cells outlining the joint mesoderm demonstrated a 
specifi  c Tgfbr2 recombination and subsequent loss of the 
fl  oxed   alleles (Tgfbr2 exon 2) in Tgfbr2
Prx1KO joints compared 
with  Tgfbr2
fl  ox/fl  ox (Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200611031/DC1). Furthermore, quantitative real-
time PCR of genomic DNA extracted from Tgfbr2
Prx1KO and 
Tgfbr2
fl  ox/fl  ox forelimb- and hindlimb-dissected digit bones and 
interphalangeal joints after removal of the skin and surrounding 
tissues showed that the effi  ciency of deletion of the Tgfbr2 exon 2 
was 92 ± 3.0% (n = 3 mice for each group); considering the 
heterogeneity of the sample, effi  ciency is considerable.
TGF-𝗃 signaling initiates joint interzone 
formation, determining chondrocyte 
segmentation and interzone cell survival
Initiation of the joint interzone is demarked by segmentation 
of the cartilaginous continuity across the future joint location 
(for review see Archer et al., 2003). In Tgfbr2
Prx1KO mutants at 
E16.5, we found a persistence of Collagen 2–expressing chon-
drocytes along the whole digit, including the potential joint site, 
whereas in control animals at the same age, Collagen 2 expres-
sion was confi  ned to the endochondral templates and absent 
in the fully demarked joint (Fig. 6 A). Several components of 
the Notch system are expressed in articular cartilage, and a 
Notch-1– positive population of progenitor joint cells has been 
recently isolated from articular cartilage. This leads to the hypo-
thesis that Notch signaling within the articular cartilage blocks 
chondrocyte differentiation, maintaining clonality and prolifer-
ation of the progenitor joint-forming cells (Hayes et al., 2003; 
Dowthwaite et al., 2004). In mice, interzone develops at E12.5–
13.5. We found that E13.5 Tgfbr2
Prx1KO mutants failed to form 
the interzone and lacked Jagged-1 expression, whereas in con-
trol mice, interzone cells highly expressed Jagged-1 (Fig. 6 B). 
It has been postulated that apoptosis may play a role in deter-
mining the fate of differentiated chondrocytes within the devel-
oping joint (for review see Archer et al., 2003). An intense 
positive TUNEL staining for apoptotic nuclei was observed 
in  E13.5 control forming joints, whereas Tgfbr2
Prx1KO E13.5 
mutants lacked cell apoptosis within the presumptive joint 
region (Fig. 6 C).
TGF-𝗃 signaling is required for joint 
morphogenic gene expression
The activation of Noggin transcription is critical for joint forma-
tion, although its regulation is unknown. Mice that are null mu-
tants for Noggin lack joints, and Noggin heterozygous loss of 
function mutations are found in some of the patients with proxi-
mal symphalangism (SYM1-OMIM185800) that lack proximal 
and medial interphalangeal joints, whereas the distal interpha-
langeal joint is never affected (Brunet et al., 1998; Gong et al., 
1999; Takahashi et al., 2001). Analysis of Noggin expression at 
E13.5 and 16.5 by in situ hybridization and immunofl  uorescence 
revealed a complete down-regulation in the joints of Tgfbr2
Prx1KO 
embryos (Fig. 7, A and B). Gdf-5 is one of the earliest markers 
expressed in developing joints, and Gdf-5 is mutated in the 
brachypodism mouse, which has interphalangeal joint defects 
(Storm et al., 1994). Furthermore, a Gdf-5 mutation with a 
gain of aberrant BMP-2–like function was reported in a family 
with SYM1 (Seemann et al., 2005). It has been hypothesized that 
in early chondrogenesis, Gdf-5 inhibits joint formation and induces 
cartilage development, whereas its role in late chondrogenesis 
Figure 5.  In the developing interphalangeal joint interzone, the T𝗃RII is 
highly and speciﬁ  cally expressed, and the R-Smad signaling is activated. 
(A–C) E12.5 (A) and E16.5 (B and C) Tgfbr2-GFP-β−GEO-BAC forelimbs 
were subjected to X-galactosidase staining. Intense staining is present in 
the proximal and medial interphalangeal joints (A and B) as well as in the 
elbow and shoulder joints (B). (C) Cryosection of an E16.5 forelimb medial 
interphalangeal joint conﬁ  rmed intense staining. (D) Parafﬁ  n sections of an 
E16.5 medial interphalangeal joint from the Tgfbr2
ﬂ  ox/ﬂ  ox control and 
Tgfbr2
Prx1KO mutant were subjected to TβRII immunoﬂ  uorescence (IF; top), 
Tgfbr2 in situ hybridization (ISH; middle), and immunohistochemistry for 
phosphorylated Smad-2 (IHC; bottom). Immunoﬂ  uorescence for TβRII was 
visualized by Cy3 ﬂ  uorescence (red), and nuclei were counterstained with 
Hoechst 33258 (blue). In Tgfbr2
ﬂ  ox/ﬂ  ox, Tgfbr2 was expressed in the joint 
cells and in the phalangeal prehypertrophic chondrocytes. The Tgfbr2
Prx1KO 
mutants lacked Tgfbr2 expression in the joints and chondrocytes. Nuclear 
immunostaining for phosphorylated Smad-2 was visualized in brown, and 
sections were counterstained using hematoxylin. Nuclei of joint cells from 
Tgfbr2
ﬂ  ox/ﬂ  ox mice showed an intense phosphorylated Smad-2 staining that 
was abrogated in Tgfbr2
Prx1KO mutant joints and largely in the phalangeal 
chondrocytes, providing evidence that TβRII signaling is activated in nor-
mal joints but abrogated in mutants. Studies were performed in at least two 
sections for each antibody and six sections for the Tgfbr2 probe; sections 
were obtained from at least two mutant and control embryos.JCB • VOLUME 177 • NUMBER 6 • 2007  1110
is to maintain joint formation (Storm and Kingsley, 1999). In 
Tgfbr2
Prx1KO mutants, Gdf-5 expression was increased at E13.5, 
whereas it was abrogated in E16.5 (Fig. 7, A and B). Wnt9a is 
expressed in developing joints, and its misexpression in chicken 
digit rays induces ectopic joint formation, whereas the loss of 
Wnt9a in mice results in synovial chondromatosis (Hartmann and 
Tabin, 2001; Spater et al., 2006). In Tgfbr2
Prx1KO mutant joints, 
Wnt9a expression is down-regulated in E13.5 (not depicted) and 
16.5 (Fig. 7 B). These results indicate that TGF-β signaling in 
developing limbs is mandatory for joint formation and to regu-
late Noggin, Gdf-5, and Wnt9a expressions.
TGF-𝗃 signaling regulates Noggin 
expression and BMP activity in limb 
bud micromass cultures
It is diffi  cult to infer from the results found in Tgfbr2
Prx1KO 
mutants whether TGF-β signaling directly regulates Noggin 
transcription or whether TGF-β sustains the limb bud growth, 
ensuring an adequate environment for the joints to develop 
and Noggin to be expressed. Therefore, we decided to evaluate 
the role of TGF-β signaling in Noggin expression in limb 
bud micromass cultures. In Cre
+Tgfbr2
KO cultures, Tgfbr2 ex-
pression was conditionally inactivated, and the lack of TβRII 
binding expression was verifi  ed by a 
125I–TGF-β1 affi  nity cross-
linking cell surface–binding assay (Fig. S2 A, available at 
http://www.jcb.org/cgi/content/full/jcb.200611031/DC1). In control 
Figure 6.  TGF-𝗃 signaling is needed for chondrocyte segmentation and 
interzone cell apoptosis. (A) Parafﬁ  n sections of an E16.5 hindlimb medial 
interphalangeal joint from the Tgfbr2
Prx1KO mutant and Tgfbr2
ﬂ  ox/ﬂ  ox control 
were subjected to in situ hybridization for Collagen 2. In Tgfbr2
Prx1KO 
mutants, at the site where the presumptive joints should have formed, a 
persistence of Collagen 2 expression was found, as indicated by asterisks. 
(B) Parafﬁ  n sections of an E13.5 medial interphalangeal joint from the 
Tgfbr2
Prx1KO mutant and Tgfbr2
ﬂ  ox/ﬂ  ox control were subjected to immuno-
histochemistry analyses for Jagged-1 expression. The sections were lightly 
counterstained with hematoxylin. In control embryos, an intense Jagged-1 
expression was detected in the interzone cells, whereas mutants lacked 
any detectable Jagged-1 in the presumptive joints. The increased cell den-
sity noted at the presumptive joint sites of the mutant is a sporadic ﬁ  nding 
most likely caused by a technical problem during the sectioning process. 
(C) Parafﬁ  n sections of an E13.5 medial interphalangeal joint from the 
Tgfbr2
Prx1KO mutant and Tgfbr2
ﬂ  ox/ﬂ  ox control were subjected to TUNEL assay, 
and fragmented DNA of apoptotic cells were visualized as brown nuclei. 
The sections were lightly counterstained with hematoxylin. In control em-
bryos, an intense staining of apoptotic nuclei was visualized in the inter-
zone, Tgfbr2
Prx1KO mutants lacked the interzone, and no sign of apoptosis 
was detected in the presumptive joint. Studies were performed in at least 
two sections for Jagged-1 antibody and TUNEL assay and at least six sec-
tions for the Collagen 2 probe; sections were obtained from at least two 
mutant and control embryos.
Figure 7.  TGF-𝗃 signaling is essential for Noggin, Gdf-5, and Wnt9a 
  expression in the interphalangeal joints. (A and B) Parafﬁ  n sections of an 
E13.5 (A) and E16.5 (B) hindlimb medial interphalangeal joint from the 
Tgfbr2
Prx1KO mutant and Tgfbr2
ﬂ  ox/ﬂ  ox control were subjected to in situ hy-
bridization (ISH) for Noggin (Nog; A and B, top), immunohistochemistry 
(IHC) for Noggin (B, second row), in situ hybridization for Gdf-5 (B, third 
row), and Wnt9a (B, fourth row). Tgfbr2
Prx1KO mutants showed a down-
  regulation of Noggin at E13.5 and E14.5; Gdf-5 was up-regulated at E13.5, 
whereas it was down-regulated at E16.5; Wnt9a was down-regulated at 
E16.5. Arrows indicate the control developing interzone joint. Studies 
were performed in at least two sections for Noggin antibody and at least 
six sections for the Noggin, Gdf-5, and Wnt9a probes; sections were ob-
tained from at least two mutant and control embryos.TGF-β SIGNALING IN JOINT DEVELOPMENT • SPAGNOLI ET AL. 1111
MMP
+Tgfbr2
fl  ox/fl  ox cultures, the TβRI, TβRII, and TβRIII were 
identifi  ed, whereas in Cre
+Tgfbr2
KO cultures, 
125I–TGF-β1 bind-
ing to TβRII was greatly reduced (Fig. S2 A). The specifi  city 
of 
125I–TGF-β1 binding was confi  rmed by the fact that labeled 
bands were displaced by cold TGF-β1 in excess (Fig. S2 A). Cre 
recombination was also confi  rmed by an intensely positive 
X-galactosidase staining in Cre
+Tgfbr2
KO-R26R that was negative 
in control MMP
+Tgfbr2
fl  ox/fl  ox-R26R cultures (Fig. S2 B). 
We found that in MMP
+Tgfbr2
fl  ox/fl  ox cultures, TGF-β treat-
ment induced Noggin mRNA and protein expression as deter-
mined by quantitative RT-PCR and Western immunoblotting 
(WIB) analyses (Fig. 8, A and B). Similar results were found 
when wild-type micromass cultures were treated with TGF-β 
(7.8 ± 2.1-fold compared with untreated control [1.2 ± 0.3-
fold]; P < 0.05; n = 3). Noggin binds to BMPs, preventing BMP 
receptor activation and, therefore, signaling; the canonical BMP 
signal is through the phosphorylation cascade of Smad-1, -5, 
and -8 that complex and induce transcription. Therefore, in ac-
cordance with the increase of Noggin expression, we found that 
in MMP
+Tgfbr2
fl  ox/fl  ox cultures, TGF-β decreased BMP activity, 
as indicated by a decrease of phosphorylated Smad-1, -5, and -8 
(Fig. 8 B). Knocking out the TGF-β signaling in Cre
+Tgfbr2
KO 
cultures resulted in the abrogation of TGF-β effects on Noggin 
expression and Smad-1, -5, and -8 phosphorylation (Fig. 8, 
A and B). Notably, a decrease of Smad-1, -5, and -8 phosphory-
lation was found in untreated Cre
+Tgfbr2
KO compared with 
MMP
+Tgfbr2
fl  ox/fl  ox cultures, possibly as a result of the unrespon-
siveness of Cre
+Tgfbr2
KO cells to endogenous TGF-β.
TGF-𝗃 signaling in autopod endochondral 
cartilage development
It has been hypothesized that the developing joints act as sig-
naling centers to control the adjacent endochondral template 
development (for review see Archer et al., 2003). Because the 
Tgfbr2
Prx1KO mutant lacks the interphalangeal joints, it repre-
sents an ideal model to test this hypothesis. Therefore, we per-
formed a systematic evaluation of cartilage marker expressions 
in growth plates adjacent to the presumptive interphalangeal 
joints at E13.5, E16.5, and postnatal day (P) 0 in Tgfbr2
Prx1KO 
mutants and control Tgfbr2
fl  ox/fl  ox siblings (Fig. 9, A–C). We 
found that Tgfbr2
Prx1KO growth plates presented several remark-
able and selective abnormalities; Collagen 10 expression is con-
sistently decreased at E13.5, E16.5, and P0 compared with 
Tgfbr2
fl  ox/fl  ox controls, indicating a dramatic delay in chondro-
cyte hypertrophy in the mutants (Fig. 9, A–C). Conversely, in 
Tgfbr2
Prx1KO growth plates, Indian hedgehog (Ihh) was increased 
and more widely expressed from the proliferative zone to the 
canonical prehypertrophic chondrocyte zone compared with 
Tgfbr2
fl  ox/fl  ox controls; this fi   nding was consistent at E13.5, 
E16.5, and P0 (Fig. 9, A–C). In Tgfbr2
Prx1KO mutants at E16.5 
and P0, parathyroid hormone–related protein (PTH-rP) expres-
sion is increased and more diffuse in the prehypertrophic/upper 
proliferative zone and in the perichondrium; at E13.5, PTH-rP 
expression is similar to the control (Fig. 9, A–C). Collagen 2 
and Sox-9 expressions are similar to the control in Tgfbr2
Prx1KO, 
but Collagen 2–expressing cells at P0 display a less organized 
columnar distribution than controls (Fig. 9, A–C). This disorga-
nization was also observed in the hematoxylin and eosin staining 
that also showed that hypertrophic chondrocytes are larger but 
show a decreased expression of Collagen 10 (Fig. 9 C). 
Discussion
The role of TGF-β signaling in skeletogenesis is not well deter-
mined, and contradictory data have been reported (for review 
see Dunker and Krieglstein, 2000). We have generated the 
Tgfbr2
Prx1KO mutant mice in which the Tgfbr2 is conditionally 
inactivated in limb buds and a subset of mesenchyme tissues start-
ing at very early embryonic limb development. The Tgfbr2
Prx1KO 
Figure 8.  TGF-𝗃 signaling up-regulates Noggin and down-regulates BMP 
activity. (A–C) Micromass cultures of mesenchymal limb bud cells were ob-
tained from E11.5 Tgfbr2
ﬂ  ox/ﬂ  ox mice. To knockout Tgfbr2, cultures were 
retrovirally infected either with the HR-MMPCreGFP vector (Cre recombi-
nase) to generate Cre
+Tgfbr2
KO micromasses or with MMP-GFP empty vec-
tor to generate MMP
+Tgfbr2
ﬂ  ox/ﬂ  ox micromasses. mRNA and cell lysates 
were obtained from cultures treated with or without 20 ng/ml TGF-β for 36 h 
and were subjected to quantitative RT-PCR (A) or WIB (B) for Noggin 
expression or WIB (C) for phosphorylated Smad-1, -5, and -8. Noggin ex-
pression was normalized to glyceraldehyde-3-phosphate dehydrogenase 
expression and expressed as fold of increases compared with the lowest 
value found in the untreated control, which was given an arbitrary value 
of 1. TGF-β induced Noggin mRNA and protein expressions, and the effect 
was abrogated in Cre
+Tgfbr2
KO micromasses. In accordance with the in-
crease of Noggin expression, we found that in MMP
+Tgfbr2
ﬂ  ox/ﬂ  ox cultures, 
TGF-β induced a down-regulation of BMP activity as documented by a de-
crease of Smad-1, -5, and -8 phosphorylations; consistently, TGF-β action 
was abolished in Cre
+Tgfbr2
KO micromasses. Membranes were probed 
with anti–β-actin antibody as an internal control for the protein amount 
loaded. For WIB densitometric analysis, band intensity was quantiﬁ  ed, 
and background intensity was subtracted and normalized by the respective 
β-actin band intensity. Plots are represented, and mean ± SD (error bars) 
as the fold increase over control is given. *, P < 0.05 versus untreated 
MMP
+Tgfr2
ﬂ  ox/ﬂ  ox by one-way analysis of variance; n = 3.JCB • VOLUME 177 • NUMBER 6 • 2007  1112
mouse allowed us to determine that TGF-β signaling is essen-
tial for interphalangeal joint development. TGF-β signaling ini-
tiates the joint interzone formation by regulating interzone cell 
survival and chondrocyte segmentation. TGF-β elicits these 
effects operating upstream of Noggin, GDF-5, and Wnt9a 
 expressions. Our results uncover a novel step regulated by TGF-β 
signaling that is required for establishing the correct initiation 
of joint development.
T𝗃RII and signaling are expressed 
in the limb joints
Although a role of TGF-β signaling in joints has been specu-
lated, TβRII expression in joints has never been clearly re-
ported. To incontrovertibly defi  ne that TβRII is expressed in 
developing interphalangeal joints, we generated the Tgfbr2-
GFP-β−GEO-BAC mouse reporter transgene and used immuno-
fl  uorescence and in situ hybridization studies. Furthermore, 
we found a high staining of phosphorylated Smad-2 in the inter-
zone cell nuclei, corroborating the fi  nding that TβRII is ex-
pressed in the cells, demarking the interzone and signaling 
through the R-Smad pathway. The Tgfbr2-GFP-β−GEO-BAC 
mouse allowed us to observe that Tgfbr2 is also highly ex-
pressed in the proximal limb joints. The Tgfbr2
Prx1KO mutants 
lack only the interphalangeal joints, whereas the proximal limb 
joints are formed. It may be possible that the Prx-1–mediated 
Cre recombination expression varies within the limb and is pres-
ent in the interphalangeal joints, whereas it is lacking or less 
  effective in the proximal limb joints. Another possibility is 
that TGF-β signaling is essential for interphalangeal joint de-
velopment, whereas it is dispensable for development of the 
proximal limb joints. The effi  ciency and specifi  city of the Prx-1–
mediated Cre recombination of TβRII in the joints was sup-
ported by the in situ hybridization and immunofl  uorescence 
studies and by the PCR amplifi  cation analyses of joint cell DNA 
obtained by LCM of joint cells or from digit bones and inter-
phalangeal joints.
Figure 9.  TGF-β signaling in cartilage development: 
lack of joint development is associated with selective 
effects on the adjacent chondrogenesis. (A–C) Parafﬁ  n 
sections of E13.5 (A), E16.5 (B), and P0 (C) growth 
plates adjacent to the (presumptive) interphalangeal 
joint of the Tgfbr2
Prx1KO mutant and Tgfbr2
ﬂ  ox/ﬂ  ox con-
trol were subjected to in situ hybridization for Sox-9 
(A and B, top), Collagen 2 (A and B, second rows; and 
C, top), Ihh (A and B, third rows; and C, second row), 
Collagen 10 (A and B, fourth rows; and C, third row), 
PTH-rP (A and B, bottom; and C, fourth row), or hema-
toxylin and eosin staining (C, bottom). Tgfbr2
Prx1KO 
mutants showed an up-regulation of Ihh and a down-
regulation of Collagen 10 expressions at all stages. 
Collagen 2 and Sox-9 expressions were similar in 
Tgfbr2
Prx1KO and control, but Collagen 2–expressing 
cells at P0 display a less organized columnar distribution 
than controls. PTH-rP expression in E13.5 Tgfbr2
Prx1KO 
mutants is similar to the control, whereas at E16.5 and 
P0, it is increased in the perichondrium and especially 
in the prehypertrophic/upper proliferative cells. Stud-
ies were performed in at least six sections for each 
probe that were obtained from at least two mutant and 
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TGF-𝗃 signaling is essential for 
interzone formation
Joints in Tgfbr2
Prx1KO mutants appear to be arrested in their de-
velopment at about the time at which interzone starts to develop: 
differentiated chondrocytes extend with a continuous pattern 
across the phalanges without any sign of apoptosis, and inter-
zone cells lack Jagged-1 expression and any sign of condensation. 
The molecular mechanisms underlying interzone formation are 
not yet well understood. Although Wnt9a was reported as a 
potential joint inducer, the recent report that Wnt9a-null 
mice have joints has redefi  ned its role more as a joint keeper 
(Hartmann and Tabin, 2001; Spater et al., 2006). GDF-5 is highly 
expressed in developing joints. It has been hypothesized that 
in early chondrogenesis (E14.5), Gdf-5 inhibits joint formation 
and induces cartilage development, whereas at a later stage of 
chondrogenesis (E15.5), it regulates joint structure formation or 
maintenance (Storm and Kingsley, 1999). Our data indicate 
that TGF-β signaling down-regulates joint GDF-5 expression 
at an early chondrogenesis stage, whereas it up-regulates its joint 
expression at a later stage, suggesting that it operates upstream 
of GDF-5.
Another conundrum in understanding joint interzone de-
velopment is the fate of differentiated chondrocytes and in the 
meantime emergence of the interzone cells. It has been recently 
reported that a distinct mesenchymal cell population takes part 
in the interzone and articular layer formation (Pacifi  ci et al., 
2006). Furthermore, a Notch-1–positive progenitor cell popula-
tion has been recently isolated within the articular cells. These 
Notch-1 progenitors are capable of engrafting in vivo into 
articular structures and have been hypothesized to maintain 
articular cartilage integrity, preserving interzone cell clonality 
and proliferation while preventing differentiation into chondro-
cytes (Dowthwaite et al., 2004). To corroborate this hypothesis, 
a derangement of the Notch signaling has been reported in 
articular synoviocytes from patients with rheumatoid arthritis 
that is characterized by aberrant synoviocyte proliferation (Ando 
et al., 2003). A direct cross talk between the Notch and TGF-β 
signaling pathways comes from a recent study in which a direct 
interaction between Notch intracellular domain and Smad-3 was 
demonstrated, and activation of Smad-3 by TGF-β led to an en-
hancement of Notch-induced Hes1 gene transcription (Blokzijl 
et al., 2003). We hypothesize that TGF-β serves as an essential 
joint signaling center and that activating Notch signaling forces 
progenitor interzone cells to remain in an undifferentiated state 
while regulating the apoptosis of differentiated chondrocytes. 
Our hypothesis needs further investigation, and the possibility 
that down-regulation of Jagged-1 in the Tgfbr2
Prx1KO mutants 
is consequent to the lack of interzone formation should also be 
considered. In bone marrow–derived mesenchymal stem cells, 
we have previously reported that TGF-β induces chondrogen-
esis by exerting similar dichotomic effects (Longobardi et al., 
2006). Deciphering the role of TGF-β signaling in joint devel-
opment can provide substantial insight to identify the interzone 
cells and to defi  ne the role of chondrocyte-programmed cell 
death and progenitor interzone cell survival in joint formation.
The TGF-β ligand expression pattern in developing cartilage 
has been previously reported, including by our group (Pelton 
et al., 1991a,b; Lawler et al., 1994). TGF-β1 is expressed in the 
digit perichondrium at E13.5, and, by E16.5, TGF-β2 and -β3 
are also expressed in the perichondrium, including in the digit 
perichondrium (Millan et al., 1991; Pelton et al., 1991a,b; 
Lawler et al., 1994; Serra and Chang, 2003). It has been previ-
ously reported that in cartilage development, TGF-βs exert 
their actions in a paracrine fashion (Lawler et al., 1994). We hy-
pothesize that a similar mechanism occurs during digit joint 
  development. Future studies are needed to evaluate TGF-β ligand 
delivery to the interphalangeal joints.
T𝗃RII operates upstream of joint gene 
expression, induces Noggin expression, 
and modulates BMP activities in vitro
Our data indicate that TGF-β signaling in the joints functions as 
a master regulator for expression of the key joint morphogenic 
genes GDF-5, Noggin, and Wnt9a. We propose a working hy-
pothesis model for joint development in which TGF-β signaling 
is essential in inducing the joint interzone formation, and it 
  operates early in joint development to regulate the expression of 
critical joint morphogenic genes such as Noggin to modulate 
BMP activities (Fig. 10).
The joint phenotype observed in the Tgfbr2
Prx1KO mouse is 
similar to that in patients with proximal symphalangism (SYM1-
OMIM185800) in which the proximal and medial interphalan-
geal joints are lacking, whereas the distal interphalangeal joint 
is not affected (Gong et al., 1999; Takahashi et al., 2001). Al-
though functionally the distal interphalangeal joint is indistin-
guishable from the other interphalangeal joints, the observation 
of phenotypical abnormalities only affecting the proximal and 
medial interphalangeal joints in patients with SYM1 and now in 
the Tgfbr2
Prx1KO mouse indicates a distinct development for the 
distal joint. In patients with SYM1, heterozygous mutations of 
Noggin as well as a heterozygous mutation of GDF-5 with an 
aberrant BMP-like gain of function have been reported (Gong 
et al., 1999; Seemann et al., 2005). Furthermore, Noggin-null 
mutant mice lack joint development (Brunet et al., 1998). These 
fi  ndings clearly indicate that lack of Noggin function or increase 
in BMP activities result in the failure of joint development. The 
regulatory factors that determine Noggin expression within the 
joints are unknown. Our data indicate that Noggin expression is 
down-regulated in the Tgfbr2
Prx1KO mouse, and, in limb bud 
 cultures,  TGF-β induces Noggin expression and reduces BMP 
signaling. Gazzerro et al. (1998) have previously reported that 
TGF-β1 induces Noggin mRNA in cultured rat osteoblasts with 
unclear function. Our working hypothesis is that TGF-β signaling 
induces joint development by regulating Noggin expression 
and, therefore, BMP activities. However, considering the multi-
ple and diverse limb abnormalities found in the Tgfbr2
Prx1KO 
phenotype, it seems likely that more than one mechanism would 
be involved. We have noted that in E13.5 mutants compared 
with controls, Noggin mRNA was increased in the surrounding 
tissue but was not increased at E16.5; on the other hand, at 
E16.5, we noted an increase of protein expression. We hypothe-
size that at E13.5, the lack of Noggin joint expression leads to a 
compensatory response in the surrounding tissue that is associ-
ated with an increase of protein expression still detectable at JCB • VOLUME 177 • NUMBER 6 • 2007  1114
E16.5 (probably as a result of a prolonged protein half-life). 
However, at E16.5, this mRNA compensatory response seems 
to be defective. Future studies are needed to identify the mecha-
nisms responsible for this compensatory response. In the con-
trols, Noggin expression in the surrounding tissue is greater 
at E16.5 than at 13.5; the signifi  cance of this increase is also 
unclear, and further studies outside of the scope of the present 
experiments are needed to determine this.
TGF-𝗃 signaling in cartilage development: 
lack of joint development is associated 
with selective effects on the adjacent 
chondrogenesis
We have found that in Tgfbr2
Prx1KO mutants, the growth plates 
adjacent to the interphalangeal joints present an increase of Ihh 
expression and a decrease of Collagen 10 expression at early as 
well as late chondrogenesis; PTH-rP expression is increased in 
late chondrogenesis. GDF-5–releasing beads implanted in the 
interdigital space of developing mouse limbs resulted in an in-
crease of Ihh expression that has also been noted in Noggin-null 
mutant mice. Up-regulation of Ihh signaling in Patched-1
−/−;
Collagen 2a1-Cre mice resulted in joint fusion (Brunet et al., 
1998; Storm and Kingsley, 1999; Mak et al., 2006). We hypoth-
esize that TGF-β signaling within the joints plays a central role 
in orchestrating the interplay between joint formation and 
adjacent endochondral template development by controlling 
Ihh expression that induces PTH-rP and, thus, repressing the 
rate of chondrocyte hypertrophy. Interestingly, in Tgfbr2
Prx1KO 
mutants, PTH-rP expression is increased in the perichondrium 
but more remarkably in the prehypertrophic/upper proliferative 
cells. Using a PTH-rP–LacZ reporter mouse, Chen et al. (2006) 
have recently reported that PTH-rP is expressed in this sub-
population of cells. The role of these PTH-rP–expressing cells is 
still not clearly defi  ned, but they may contribute to the PTH-rP 
inhibitory effect on hypertrophy (Chen et al., 2006). Hematoxy-
lin and eosin morphometric analysis showed that hypertrophic 
chondrocytes seem to be larger in P0 Tgfbr2
PRX-1KO mutants, but 
Collagen 10 expression was clearly decreased at any stage, in-
dicating a functional derangement. These fi  ndings are consis-
tent with our hypothesis that TGF-β signaling is required for 
the appropriate progression of the prehypertrophic to hypertro-
phic chondrocytes, and its abolishment is associated with a de-
rangement of the pre- and hypertrophic growth plate zones.
Our data are only apparently in contradiction with the fi  nd-
ings observed in Tgfbr2
fl  ox/fl  oxCollagen 2a-cre mice in which Tgfbr2 
was conditionally inactivated in Collagen 2a–expressing cells. In 
the Tgfbr2
fl  ox/fl  ox Collagen 2a-cre mouse, chondrocyte differentia-
tion and development of long bones are normal. We hypothesize 
Figure 10.  TGF-𝗃 is a master signaling center within the 
joint interzone. Proposed model for the role of TβRII signaling 
in interphalangeal joint development. TβRII is speciﬁ  cally ex-
pressed by the joint-developing cells, and lack of TGF-β sig-
naling results in the failure of interzone formation by lack of 
the survival of interzone-forming cells, persistence of differen-
tiated chondrocytes in the joint region, and derangement of 
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that in the endochondral growth process, TGF-β signaling is 
required to control the rate of differentiation of prehyper-
trophic chondrocytes to hypertrophic chondrocytes, whereas it 
has relatively scarce effect on collagen 2–expressing chondro-
cytes. An increase of Ihh expression was found in the growth 
plates of newborn DNIIR, and, by 1–2 mo of age, these mice 
develop progressive osteoarthritis with replacement of the 
articular cartilage with Collagen X– expressing cells (Serra et al., 
1997). We speculate that over time, DNIIR mice develop a 
compensatory mechanism that overrides the Ihh inhibitory effect 
on hypertrophy.
TGF-𝗃 signaling regulates 
calvaria development
The  Tgfbr2
Prx1KO mouse lacks the parietal and interparietal 
bones. Interestingly, a similar phenotype has been reported in 
patients with familial parietal foramina (PFM-1, OMIM168500 
PFM-2, and OMIM609597) that have symmetrical, oval de-
fects in the parietal bones. Some of these patients have been 
reported to have haploinsuffi   ciency either in the homeobox 
gene Alx4 (OMIM609597) or in the Msx2 gene (OMIM168500; 
Wuyts et al., 2000a,b) In mice, Msx2, Twist, and Alx4 cooper-
ate in controlling the migration and differentiation of crest-
derived skeletogenic mesenchyme in the vault (Ishii et al., 2003; 
Antonopoulou et al., 2004). Cranio-facial conditional inactiva-
tion of Tgfbr2 in the Tgfbr2
fl o x / fl o x;Wnt1-cre mouse also resulted 
in calvaria defects (Ito et al., 2003). We have noted that in the 
Tgfbr2
Prx1KO-R26R mouse, the LacZ-stained cells are arrested 
below the parietal and interparietal bones (Fig. 5, A and B), 
whereas in controls, LacZ-stained cells cover the vault (not 
depicted). The fl  at bones of the skull vault develop from two 
migratory mesenchymal cell populations, the cranial neural 
crest, and paraxial mesoderm. The possibility that a defect in 
migration of the Tgfbr2
Prx1KO skeletogenic mesenchyme cells 
within the vault can lead to the vault bones and the interplay 
between TGF-β signaling with Msx2, Twist, and Alx4 genes is 
under investigation, and further studies are needed. In conclu-
sion, the Tgfbr2
Prx1KO mouse model has unraveled critical in-
formation on skeletal development and opened novel potential 
therapeutic approaches to treat degenerative joint diseases such 
as osteoarthritis.
Materials and methods
Generation of Tgfbr2
Prx1KO, Tgfbr2-GFP-𝗃−GEO-BAC, 
and Tgfbr2
Prx1KO-R26R mice
To generate Tgfbr2
Prx1KO mutants, female Tgfbr2
ﬂ  ox/ﬂ  ox homozygous mice 
were mated with Prx1-Cre and Tgfbr2
ﬂ  ox heterozygous males (Chytil et al., 
2002; Logan et al., 2002). As previously reported, we have generated the 
Tgfbr2
ﬂ  ox/ﬂ  ox mouse by ﬂ  anking with loxP sites the exon 2 of TβRII that tran-
scribes for the TGF-β–binding domain (Chytil et al., 2002). In the Prx1-Cre 
mouse (a gift from C. Tabin, Harvard Medical School, Boston, MA), a Prx1 
limb enhancer drives Cre recombinase expression in limb buds and in cal-
varia mesenchyme beginning at E9.5 (Logan et al., 2002). Genotyping 
was performed using PCR primers for loxP and Cre (Chytil et al., 2002). 
Because a penetrant germline recombination has been reported when 
crossing Prx1-Cre females with mice carrying ﬂ   oxed genes, only Cre
+ 
males were used (Logan et al., 2002). Cre
+Tgfbr2
ﬂ  ox/− males (Swiss-Webster 
background) were backcrossed propagated to C57BL/6 Tgfbr2
ﬂ  ox/ﬂ  ox females, 
and experiments were performed in mice that were in the C57BL/6 strain 
for at least eight generations.
To generate the Tgfbr2-GFP-β−GEO-BAC mouse, the mouse BAC 
clone RP24-317C21 containing Tgfbr2 was obtained from the Children’s 
Hospital Oakland Research Institute. As schematically presented in Fig. S3 
(available at http://www.jcb.org/cgi/content/full/jcb.200611031/DC1), 
a GFP-IRES-β-GEO cassette was inserted into Tgfbr2-BAC at the endo  g-
enous Tgfbr2 translational start site using the homologous recombina-
tion  technique of Warming et al. (2005), Lee et al. (2001), and as 
previously reported (Mortlock et al., 2003; Deal et al., 2006) as follows: 
the plasmid pIBGFTet was generated by ligating the IRES-β-GEO-SV40pA 
cassette from pGT1.8 and an FRT-ﬂ  anked tetracycline resistance cassette 
into a modiﬁ  ed pBluescript II SK+ backbone (Mountford et al., 1994). An 
eGFP open reading frame (CLONTECH Laboratories, Inc.) was then in-
serted upstream of IRES-β-GEO-SV40pA to create pGFPIBGFTet. The re-
combination cassette was constructed by subcloning 50-bp 5′ and 3′ 
recombination arms (both containing part of the Tgfbr2 exon 1) into pGF-
PIBGFTet such that the recombination arms ﬂ  anked the GFP-IRES-β-GEO-
FRT-Tet-FRT cassette. The forward strand (relative to Tgfbr2) sequences of 
the 50-bp homology arms were as follows: for the 5′ arm, C  G  G  T  T  C  G  T  G-
G  C  G  C  A  C  C  A  G  G  G  G  C  C  G  G  T  C  T  A  T  G  A  C  G  A  G  C  G  A  C  G  G  G  G  G  C  T  G  C  C  ; and 
for the 3′ arm, A  T  G  G  G  T  C  G  G  G  G  G  C  T  G  C  T  C  C  G  G  G  G  C  C  T  G  T  G  G  C  C  G  C  T-
G  C  A  T  A  T  C  G  T  C  C  T  G  T  G  . Both recombination arms were created by anneal-
ing PAGE-puriﬁ  ed oligonucleotides designed to allow direct ligation to 
pGFPIBGFTet. The ﬁ  nal cassette with recombination arms was digested 
from the vector, gel puriﬁ  ed, and recombined with BAC as described pre-
viously (Lee et al., 2001). Successful recombinants were selected by tetra-
cycline resistance. The tetracycline resistance gene was then removed by 
FLPe recombinase excision (Lee et al., 2001; Mortlock et al., 2003). The 
correctly modiﬁ  ed BAC was veriﬁ  ed by conventional and pulsed-ﬁ  eld gel 
analysis of restriction digests to conﬁ   rm expected banding patterns as 
well as direct BAC sequencing. Tgfbr2-BAC DNA was puriﬁ  ed according 
to established techniques and was used for pronuclear injection of 
C57BL/6J × DBA/2J F1 hybrid embryos (DiLeone et al., 2000). Injec-
tions and oviduct transfers were performed by the Vanderbilt Transgenic 
Core Facility using standard techniques in accordance with protocols ap-
proved by the Vanderbilt University Institutional Animal Care and Use 
Committee. All BACs were injected as uncut circular DNAs.
To generate the Tgfbr2
Prx1KO-R26R mouse, the Tgfbr2
ﬂ  ox/ﬂ  ox and R26R 
(obtained from P. Soriano, Fred Hutchinson Cancer Research Center, Seattle, 
WA; Soriano, 1999) were ﬁ  rst crossed to obtain the Tgfbr2
ﬂ  ox/ﬂ  ox-R26R 
female mice that were then crossed with Prx1-Cre heterozygous males. For 
timed pregnancies, noon of the day when evidence of a vaginal plug was 
found was considered E0.5.
Skeletal analysis
Alizarin red/Alcian blue staining was performed as previously reported 
(Mortlock et al., 1996). Images were taken using a stereo microscope 
(SZX16; Olympus) equipped with a digital camera (DP71; Olympus) and 
imported into Photoshop (Adobe). Living animal micro-CT imaging (Imtek 
MicroCAT-II-CT) was performed setting micro-CT slices at 40 μm that were 
then reconstructed in 3D arrays using the same thresholds.
Histology, immunoﬂ  uorescence, immunohistochemistry, TUNEL assay, 
in situ hybridization studies, and detection of 𝗃-galactosidase activity 
in whole mount embryos and cryosections
Intact or dissected limb embryos or skinned and decalciﬁ  ed newborns were 
sectioned using standard procedures. For general morphology, sections 
were stained with hematoxylin and eosin using standard procedures.
For immunohistochemistry or immunoﬂ  uorescence, either the Cytoma-
tionK41010 or VectastatinEliteABC Immunostaining kits (DakoCytomation) 
were used. The following primary antibodies were used: anti-TβRII poly-
clonal (Santa Cruz Biotechnology, Inc.), anti–Jagged-1 polyclonal (Santa 
Cruz Biotechnology, Inc.), antiphosphorylated Smad-2 polyclonal (Cell 
Signaling), and anti-Noggin polyclonal (R&D Systems). Apoptotic nuclei were 
visualized using the DeadEnd Colorimetric TUNEL System (Promega).
In situ hybridization studies were performed as previously reported 
(Deal et al., 2006). Digoxigenin-UTP-riboprobes were synthesized (DIG-
RNA-Labeling kit; Roche) from plasmids with insertion of Noggin (provided 
by R. Harland, University of California, Berkeley, Berkeley, CA), Tbr2 (pro-
vided by S.K. Dey, Vanderbilt University, Nashville, TN), mouse Collagen 
2a1 and Gdf-5 (provided by D. Kingsley, Stanford University, Palo Alto, 
CA), mouse Ihh (provided by A. McMahon, Harvard University, Cam-
bridge, MA), and PTHrP (provided by H. Kronenberg, Harvard University; 
Metsaranta et al., 1991; Storm and Kingsley, 1996; Das et al., 1997). 
Wnt9a was made using a mouse Wnt9a cDNA clone (IMAGE clone 
#30435371; GenBank/EMBL/DDBJ accession no. BC066165); the plasmid JCB • VOLUME 177 • NUMBER 6 • 2007  1116
was linearized with XmnI and riboprobe synthesized with T7 polymerase. 
Collagen 10a1 and Sox9 probes were also made. The primers for Sox9 
were forward (G  A  C  A  T  G  T  A  A  A  G  G  A  A  G  G  T  A  A  C  G  A  T  T  G  ) and reverse (A  G  G 
C  T  A  A  G  G  G  A  C  A  C  T  C  T  T  G  A  A  C  T  A  ); the primers for Collagen 10a1 were 
forward (G  C  C  A  G  G  T  C  T  C  A  A  T  G  G  T  C  C  T  A  ) and reverse (G  A  T  C  C  A  G  G  T  A  G-
C  C  T  T  T  G  C  T  G  ). PCR products were cloned into pGEMT-Easy and linearized 
with NcoI, and riboprobes were synthesized with T7 polymerase. Whole 
mount embryo X-galactosidase staining was performed as previously re-
ported (Mortlock et al., 2003). Images were taken using an inverted micro-
scope (1X71; Olympus) equipped with a digital camera (DP71; Olympus) 
and were imported into Photoshop (Adobe), where they were formatted 
without using any imaging enhancement. For cryosectioning, whole mount 
stained embryos were cryoembedded in optimal cutting temperature com-
pound (Sakura). 50-μm sections were warm adhered on Superfrost-Plus 
slides (Fisher Scientiﬁ   c), washed thoroughly, and mounted using Aqua-
Polymount (Polysciences). Section images were taken using the IX71 micro-
scope with DP71 digital camera. Sections subjected to immunoﬂ  uorescence 
were imaged using a microscope (Axiophot; Carl Zeiss MicroImaging, 
Inc.) with a camera (Micromax; Princeton Instruments), and images were 
imported into Photoshop for formatting.
Micromass cultures, in vitro conditional inactivation of T𝗃RII, 
X-galactosidase histochemical staining, and afﬁ  nity labeling with 
125I–TGF-𝗃1
Limb bud mesenchymal cells from E11.5 embryos were isolated and micro-
mass cultured as described previously (Cash et al., 1997). To conditionally 
inactivate TβRII, micromasses from Tgfbr2
ﬂ  ox/ﬂ  ox or Tgfbr2
ﬂ  ox/ﬂ  ox-R26R em-
bryos were infected either with HR-MMPCreGFP or MMP-GFP retroviral 
vectors as previously reported to generate Cre
+Tgfbr2
KO micromasses or 
MMP
+Tgfbr2
ﬂ  ox/ﬂ  ox micromasses, respectively (Silver and Livingston, 2001; 
Longobardi et al., 2006). Infections were performed 1, 24, and 48 h after 
seeding. 
125I–TGF-β1–TßR afﬁ   nity cross-linking was performed as previ-
ously reported (Longobardi et al., 2006).
WIB analysis and quantitative real-time PCR
Cell lysates and total RNA were obtained as previously reported from 
Cre
+Tgfbr2
KO micromasses or MMP
+Tgfbr2
ﬂ  ox/ﬂ  ox micromasses cultured for 
36 h and were treated with or without 20 ng/ml TGF-β (Longobardi et al., 
2006). Treatment was repeated after 24 h, and cells were harvested 12 h 
later (total TGF-β treatment time was 36 h); WIB analysis was performed 
as previously reported (Longobardi et al., 2006). Noggin and phospho-
Smad-1/-5/-8 polyclonal antibodies were obtained from Cell Signaling, 
and anti–β-actin antibody was purchased from Sigma-Aldrich. WIB im-
ages were semiautomatically analyzed using a custom-built densitometric 
image analysis code in MATLAB (Mathworks). Quantitative RT-PCR was 
performed as previously described (Longobardi et al., 2006). PCR primers 
for Noggin ampliﬁ  cation were 5′-A  A  G  G  A  G  A  A  G  G  A  T  C  T  G  A  A  C  G  A  G  A  C  G  -3′ 
and 5′-T  C  G  G  A  G  A  A  C  T  C  C  A  G  C  C  C  T  T  T  G  A  T  -3′.
Tgfbr2 deletion by genomic DNA analysis
LCM was performed as previously described (Bhowmick et al., 2004). In 
brief, E16.5 autopod parafﬁ  n sections (5 μm on uncharged slides) were 
immediately subjected to LCM on an LCM system (PixCell Iie; Arcturus). The 
captured cells were subsequently extracted for DNA ampliﬁ  cation to deter-
mine the recombination of Tgfbr2 exon 2 by PRC as previously described 
(Bhowmick et al., 2004). Genomic DNA was also obtained from E17.5 
Tgfbr2
Prx1KO and Tgfbr2
ﬂ  ox/ﬂ  ox forelimb- and hindlimb-dissected digit bones 
and interphalangeal joints after removal of the skin and surrounding tissues 
and was subjected to quantitative real-time PCR using previously reported 
primers (Chytil et al., 2002; Bafﬁ   et al., 2004).
Statistical analysis
Data are presented as mean ± SD and are analyzed using an unpaired 
t test or one-way analysis of variance (Sigmastat Software; Sigma-Aldrich). 
Statistical signiﬁ  cance was set at P < 0.05.
Online supplemental material
Fig. S1 shows recombination of the TβRII exon 2 in the joints by LCM fol-
lowed by PCR. Fig. S2 shows the recombination of Tgfr2 in Cre
+Tgfbr2
KO 
and in Cre
+Tgfbr2
KO-R26R micromass cultures. Fig. S3 shows a schem  atic 
diagram of the Tgfbr2-GFP-β−GEO-BAC reporter construct. Online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200611031/DC1.
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